Key Takeaways: Female testosterone dosing is roughly 1/10th to 1/20th of male dosing. Start at 2.5-5 mg/day topical, titrate to 5-10 mg/day based on blood work and symptoms. Target total testosterone is 50-70 ng/dL. Always start low and go slow. Signs of overdosing include acne, facial hair growth, and voice changes.
The Fundamental Rule: Start Low, Go Slow
Female testosterone dosing requires a different mindset than male TRT. In men, the target range is 700-1100 ng/dL. In women, the target is 50-70 ng/dL. The margin between therapeutic benefit and unwanted side effects is narrower, which means precision matters.
The approach:
Start at the low end of the dosing range
Check blood work at 6-8 weeks
Adjust in small increments (2.5 mg/day) every 4-6 weeks
Working with a provider experienced in women's hormone therapy makes this process safer and more effective. Find a vetted clinic that specializes in female TRT.
The "Start Low" Approach
Even within the already-conservative female range, many women do best starting at the very bottom of the curve. Standard prescribing is often 10-20mg/day of topical testosterone from day one. For some women, that's too much: acne, oily skin, irritability, sleep disruption, or a subtle "pumped up" edge that doesn't match how they want to feel on testosterone.
A more conservative alternative starts at 3-5mg/day (~1/4 the standard upper-maintenance dose) for 4-8 weeks, then titrates up only if blood work and symptoms warrant it. Reports from community and clinician notes increasingly favor this approach for women who are sensitive to hormonal changes or want a smoother adjustment curve. Some women find they never need more -- they hit target free T levels and reach their goals at the very bottom of the range.
This is not a universal recommendation. Some women -- particularly post-oophorectomy patients or those with severe deficiency -- genuinely need 7.5-10mg/day to achieve symptom relief, and slightly faster titration is appropriate. But given how narrow the window is between therapeutic and virilizing doses in women, asking your prescriber for a 4-8 week "start low, titrate slowly" phase is often the safer default.
Get Female-T Dosing Done Right
General-practice doctors often prescribe male doses to women — 10× too high. Match with a menopause-trained specialist who knows the 1-5 mg female protocol and will dose you correctly the first time.
Dosing by Delivery Method
Testosterone Cream
The most commonly prescribed form for women. Compounded at concentrations suitable for the small doses women need.
Phase
Dose
Volume (1% cream)
Duration
Starting
2.5-5 mg/day
0.25-0.5 mL
6-8 weeks
Low maintenance
5 mg/day
0.5 mL
Ongoing
Standard maintenance
7.5 mg/day
0.75 mL
Ongoing
Upper maintenance
10 mg/day
1.0 mL
Ongoing
Application: Apply once daily, preferably in the morning. Inner thigh is the most common site. Rotate between left and right thigh.
Measurement: Most compounding pharmacies provide a graduated syringe or pump mechanism for precise dosing. If using a tube, measure carefully -- small volume differences significantly affect the dose.
Similar dosing to cream, with slightly different absorption characteristics.
Phase
Dose
Notes
Starting
2.5-5 mg/day
Apply to inner forearm or thigh
Maintenance
5-10 mg/day
Titrate based on levels and symptoms
Gel absorption may be slightly faster than cream due to the alcohol base. Some women find they need slightly lower doses with gel compared to cream. Blood work at 6-8 weeks clarifies the individual response.
Pellet dosing is expressed as total milligrams per insertion, not daily dose. The pellets dissolve over 3-4 months, providing a slow, steady release.
Patient profile
Dose per insertion
Pellets
Expected duration
First pellet insertion
50 mg
1-2 pellets
3-4 months
Standard maintenance
62.5-75 mg
2-3 pellets
3-4 months
Higher maintenance
75-100 mg
2-4 pellets
3-4 months
Post-oophorectomy
75-100 mg
2-4 pellets
3-4 months
Important: Once pellets are inserted, the dose cannot be reduced. This is why first-time pellet patients should start conservatively. If you have not yet established your optimal dose with cream or gel, consider doing so before switching to pellets.
DHEA (oral): 10-25 mg/day. DHEA is a precursor that converts to testosterone, but conversion rates are unpredictable (10-15% on average). Blood levels of testosterone after DHEA supplementation vary widely between individuals. Not recommended as a primary testosterone replacement strategy.
Intramuscular injection: Rarely used in women. The lowest available testosterone cypionate concentration (200 mg/mL) makes it difficult to accurately draw up the 2-5 mg doses women need. Some compounding pharmacies produce lower-concentration injectables (20-40 mg/mL), but topical delivery is preferred for consistency.
Sublingual troches: Compounded testosterone troches dissolve under the tongue. Doses of 0.5-2 mg twice daily are used by some clinicians. Absorption is rapid but levels fluctuate more than topical methods. Limited clinical data in women.
Target Blood Levels
Total Testosterone
Target range: 50-70 ng/dL
This corresponds to the upper range of normal for premenopausal women. It is the range most clinicians associate with optimal symptom resolution.
Level
Interpretation
Below 25 ng/dL
Clearly deficient in most women
25-40 ng/dL
Low-normal; may be insufficient for symptom relief
40-50 ng/dL
Adequate for some women; may need optimization
50-70 ng/dL
Optimal therapeutic range
70-100 ng/dL
Above target; watch for androgenic side effects
Above 100 ng/dL
Supraphysiological; reduce dose
Free Testosterone
Free testosterone is the biologically active fraction. It should be measured by equilibrium dialysis (the gold standard) or calculated from total T, SHBG, and albumin.
Target: Upper quartile of the laboratory's female reference range.
Exact numbers vary by lab, but typical targets are 3-6 pg/mL (by equilibrium dialysis). The key is to ensure free testosterone is not suppressed by high SHBG, which is common in women taking oral estrogen.
SHBG Considerations
Sex hormone-binding globulin directly affects how much testosterone is bioavailable. High SHBG binds more testosterone, reducing the free fraction. Low SHBG allows more free testosterone, potentially amplifying effects at a given total T level.
Factors that increase SHBG (requiring higher testosterone doses):
Oral estrogen therapy
Hyperthyroidism
Low body weight
Aging
Factors that decrease SHBG (requiring lower testosterone doses):
Insulin resistance/obesity
Hypothyroidism
Oral androgens
PCOS
Titration Protocol
Week 1-6: Initial Phase
Start at 2.5-5 mg/day (topical) or 50 mg (pellets)
Note any side effects: acne, skin changes, hair changes
Week 6-8: First Assessment
Blood work: total testosterone, free testosterone, SHBG, estradiol, CBC
Timing: draw blood in the morning, before daily application (trough level for topicals), or 4-6 weeks post-insertion (for pellets)
Review symptom diary
Decision Points After First Labs
Total T result
Free T result
Symptoms
Action
Below 40 ng/dL
Low
Not improved
Increase dose by 2.5 mg/day
40-50 ng/dL
Low-normal
Partially improved
Increase by 2.5 mg/day
40-50 ng/dL
Normal
Improved
May maintain or modestly increase
50-70 ng/dL
Normal
Improved
Maintain current dose
50-70 ng/dL
Normal
Not improved
Evaluate other causes; may not be testosterone-related
Above 70 ng/dL
High
Side effects
Decrease dose by 2.5 mg/day
Week 12-16: Second Assessment
Repeat blood work if dose was adjusted
Symptom improvement should be more apparent
Fine-tune dosing
6-Month Evaluation
Per the Global Consensus Position Statement, assess whether testosterone therapy is providing meaningful benefit
If symptoms have not improved after 6 months at optimized levels, testosterone deficiency may not be the primary issue
If benefits are clear, continue with monitoring every 6-12 months
Signs of Overdosing
Recognize these early and reduce the dose immediately:
Early Warning Signs (Reduce Dose)
Acne, particularly along the jawline
Increased oiliness of skin and hair
Fine facial hair becoming darker or coarser
Increased body hair growth
Irritability or aggressive mood changes
Disrupted sleep
Serious Signs (Stop and Consult Provider)
Voice deepening or hoarseness
Clitoral enlargement
Significant scalp hair thinning (male pattern)
Severe acne
Menstrual irregularity (in premenopausal women not related to perimenopause)
Critical note: Voice deepening and clitoral enlargement may be irreversible. Do not ignore these symptoms. Acne and hair changes are generally reversible with dose reduction.
Special Dosing Considerations
Women on Oral Estrogen
Oral estrogen significantly increases hepatic SHBG production. This binds more testosterone and reduces the bioavailable fraction. Options:
Increase testosterone dose to compensate (may need 50-100% more than women not on oral estrogen)
Switch from oral to transdermal estrogen (patch or cream), which has less impact on SHBG
Monitor free testosterone specifically, not just total T
Women After Oophorectomy
Surgical menopause causes abrupt testosterone loss. These women often need doses at the higher end of the range (7.5-10 mg/day cream) and may benefit from faster titration since the deficiency is sudden and severe.
Younger Premenopausal Women
Dosing in younger women should be more conservative. Start at the lowest effective dose (2.5 mg/day) and titrate slowly. Monitor menstrual cycles for any irregularity. Effective contraception is essential if there is any pregnancy possibility, as testosterone can affect fetal development.
Women With PCOS History
Women with a history of PCOS may have increased androgen receptor sensitivity. Start at lower doses and monitor closely for hyperandrogenic symptoms. Target the lower end of the therapeutic range (total T 40-50 ng/dL).
Most women use 5-10 mg/day of topical testosterone (cream or gel). Starting doses are typically 2.5-5 mg/day, with titration upward based on blood levels and symptom response over 6-8 weeks.
What testosterone level should women aim for?
The therapeutic target for total testosterone in women is generally 50-70 ng/dL, which represents the upper range of normal for premenopausal women. Free testosterone should be in the upper quartile of the female reference range.
How do you know if testosterone dose is too high?
Signs of excess testosterone in women include acne (especially jawline), increased facial or body hair, oily skin, irritability, deepening voice, and clitoral enlargement. If any of these appear, reduce the dose immediately and recheck blood work.
Do women on oral estrogen need more testosterone?
Often yes. Oral estrogen increases SHBG production, which binds more testosterone and reduces the free (active) fraction. Women on oral estrogen may need higher testosterone doses to achieve adequate free testosterone levels. Switching to transdermal estrogen can help by lowering SHBG.
